![Gary Gordon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gary Gordon
Direktor/Vorstandsmitglied bei BioSight Ltd.
Aktive Positionen von Gary Gordon
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BioSight Ltd.
![]() BioSight Ltd. Miscellaneous Commercial ServicesCommercial Services BioSight Ltd. is a clinical stage biotechnology company engaging in the development of therapeutics for hematological malignancies and disorders. The company was founded by Stela Gengrinovitchan and Mark Gengrinovitch on November 10, 1999 and is headquartered in Lod, Isreal. | Direktor/Vorstandsmitglied | 18.05.2020 | - |
PhotonPharma, Inc.
![]() PhotonPharma, Inc. BiotechnologyHealth Technology PhotonPharma, Inc. is developing the Innocell therapeutic cancer vaccine, which is a personalized therapy using autologous tumor tissue. The company is based in Fort Collins, CO at the Research Innovation Center of Colorado State University. The technology is based on a photochemical inactivation platform that uses riboflavin (vitamin B2) and UV light to render tumor cells incapable of replication while still allowing them to metabolize, express proteins, present antigens, and stimulate immune recognition and response mechanisms. In combination with selected adjuvants, Innocell has shown the ability to prevent metastatic tumor formation, reduce tumor growth, and stimulate cellular immune response pathways in preclinical animal models. The company was founded in 2018 by Raymond Goodrich, and Alan S. Rudolph has been the CEO since 2018. | Direktor/Vorstandsmitglied | - | - |
Israel Biotech Fund
![]() Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Berater | - | - |
Karriereverlauf von Gary Gordon
Ehemalige bekannte Positionen von Gary Gordon
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ABBVIE INC. | Corporate Officer/Principal | - | 01.04.2018 |
G.D. Searle Co. | Private Equity Investor | - | - |
The Johns Hopkins University School of Medicine | Corporate Officer/Principal | - | - |
OVATION Pharmaceuticals, Inc.
![]() OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OVATION Pharmaceuticals, Inc. develops, manufactures and markets pharmaceuticals. It focuses on central nervous system, hematology or oncology and hospital-based therapies. The company was founded by Jeffrey S. Aronin in 2000 and is headquartered in Deerfield, IL. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
ABBOTT LABORATORIES | Corporate Officer/Principal | - | - |
ADVAXIS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2019 | - |
Ausbildung von Gary Gordon
The State University of New York | Undergraduate Degree |
The Johns Hopkins University School of Medicine | Doctorate Degree |
Stony Brook University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Israel | 4 |
2 |
Operativ
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 4 |
Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ABBVIE INC. | Health Technology |
ABBOTT LABORATORIES | Health Technology |
Private Unternehmen | 6 |
---|---|
Old Ayala, Inc.
![]() Old Ayala, Inc. Pharmaceuticals: MajorHealth Technology Old Ayala, Inc. operates as a clinical-stage oncology company. It focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. It also involved in in precision oncology, targeted therapy, drug development, companion diagnostics, and biomarkers. The company was founded in November 2017 and is headquartered in Rehovot, Israel. | Health Technology |
OVATION Pharmaceuticals, Inc.
![]() OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OVATION Pharmaceuticals, Inc. develops, manufactures and markets pharmaceuticals. It focuses on central nervous system, hematology or oncology and hospital-based therapies. The company was founded by Jeffrey S. Aronin in 2000 and is headquartered in Deerfield, IL. | Health Technology |
BioSight Ltd.
![]() BioSight Ltd. Miscellaneous Commercial ServicesCommercial Services BioSight Ltd. is a clinical stage biotechnology company engaging in the development of therapeutics for hematological malignancies and disorders. The company was founded by Stela Gengrinovitchan and Mark Gengrinovitch on November 10, 1999 and is headquartered in Lod, Isreal. | Commercial Services |
PhotonPharma, Inc.
![]() PhotonPharma, Inc. BiotechnologyHealth Technology PhotonPharma, Inc. is developing the Innocell therapeutic cancer vaccine, which is a personalized therapy using autologous tumor tissue. The company is based in Fort Collins, CO at the Research Innovation Center of Colorado State University. The technology is based on a photochemical inactivation platform that uses riboflavin (vitamin B2) and UV light to render tumor cells incapable of replication while still allowing them to metabolize, express proteins, present antigens, and stimulate immune recognition and response mechanisms. In combination with selected adjuvants, Innocell has shown the ability to prevent metastatic tumor formation, reduce tumor growth, and stimulate cellular immune response pathways in preclinical animal models. The company was founded in 2018 by Raymond Goodrich, and Alan S. Rudolph has been the CEO since 2018. | Health Technology |
G.D. Searle Co. | Commercial Services |
Israel Biotech Fund
![]() Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Finance |
- Börse
- Insiders
- Gary Gordon
- Erfahrung